首页> 外国专利> COMPOSITIONS AND METHODS FOR TREATING MATRIX METALLOPROTEINASE 9 (MMP9)-MEDIATED CONDITIONS

COMPOSITIONS AND METHODS FOR TREATING MATRIX METALLOPROTEINASE 9 (MMP9)-MEDIATED CONDITIONS

机译:用于治疗基质金属蛋白酶9(MMP9)介导的条件的组合物和方法

摘要

PROBLEM TO BE SOLVED: To provide modulation (e.g., inhibition) of MMP (e.g., MMP9).SOLUTION: Provided are methods for treating an MMP9-mediated condition or disease, comprising administration of an electrokinetically altered aqueous fluid comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures substantially having an average diameter of less than about 100 nanometers and stably configured in the ionic aqueous fluid in an amount sufficient for treating an MMP9-mediated condition or disease. The chargestabilized oxygen-containing nanostructures are preferably stably configured in the fluid in an amount sufficient to provide for modulation of cellular membrane potential and/or conductivity.
机译:解决的问题:提供对MMP(例如,MMP9)的调节(例如,抑制)。解决方案:提供了用于治疗MMP9介导的状况或疾病的方法,包括给予包括以下物质的离子水溶液的电动改变的水性液体:电荷稳定的含氧纳米结构,其平均直径基本上小于约100纳米,并且在离子水流体中稳定配置的量足以治疗MMP9介导的病症或疾病。电荷稳定化的含氧纳米结构优选以足以调节细胞膜电位和/或电导率的量稳定地配置在流体中。

著录项

  • 公开/公告号JP2015044868A

    专利类型

  • 公开/公告日2015-03-12

    原文格式PDF

  • 申请/专利权人 REVALESIO CORP;

    申请/专利号JP20140246753

  • 申请日2014-12-05

  • 分类号A61K33/08;A61K9/08;A61P43;A61K47/04;A61P11;A61P11/06;A61P37/08;A61P35;A61P19/02;A61P29;A61P9/10;A61P25;A61P25/28;A61P9;A61P17/02;A61P21/02;A61P25/14;A61P25/16;A61P25/06;A61P31/18;A61K45;A61K39/395;

  • 国家 JP

  • 入库时间 2022-08-21 15:35:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号